Background: This study is to explore the role of the minimum apparent diffusion coefficient (ADC-min) value in the diagnosis of invasive breast cancer and ductal carcinoma in situ (DCIS).
INTRODUCTION
Breast cancer is one of the most common malignant tumors in women worldwide. [1] Ductal carcinoma in situ (DCIS), which accounts for 20% of breast cancer, is a neoplastic lesion confined to ductal lobule of the breast and is characterized by malignant ductal epithelial cell proliferation. [2, 3] Early detection and treatment is the key to improve the prognosis of DCIS. Invasive ductal carcinoma (IDC) is the most common type of breast cancer, which is divided as pure IDC and IDC with DCIS (IDC-DCIS). [3] IDC may be generated from DCIS, or arise de novo. [4] IDC-DCIS has lower rate of proliferation, metastasis, local recurrence, and better prognosis when compared with pure IDC. [5] [6] [7] Therefore, preoperative diagnosis of DCIS, IDC-DCIS, and IDC is especially important for developing optimal treatment plan and predicting prognosis.
Diffusion-weighted imaging (DWI) can measure water diffusion in tissue. The apparent diffusion coefficient (ADC) is the quantized value of DWI, and low ADC values indicate restricted diffusion. [8] [9] [10] DWI is used in the detection and characterization of invasive breast tumors [11] [12] [13] and DCIS. [14, 15] The average ADC (ADC-mean) value was used in these studies. However, the minimum ADC (ADC-min) value can represent the most malignant parts of tumors. [16] So far, the correlation between ADC-min value and IDC, IDC-DCIS, and DCIS has not been fully established yet. Therefore, in this retrospective study, correlation of the ADC-min value with IDC, IDC-DCIS, and DCIS was investigated. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. 
MATERIALS AND METHODS

Study patients
A total of 362 cases of breast cancer patients who underwent breast magnetic resonance (MR) examinations from May 2014 to February 2018 were retrospectively reviewed. Among them, 23 cases with other type malignant tumors, 87 cases with benign lesions, and 18 cases with no surgical confirmation were excluded. Moreover, 38 patients who underwent chemotherapy or radiotherapy were also excluded. Finally, a total of 196 patients (mean age: 47.01 ± 9.20 years) were included in the analysis. The diagnosis was confirmed by pathology. This study was approved by the Ethics Committee of the Second Hospital of Shandong University. Due to the retrospective nature of the study, informed consent was waived.
Magnetic resonance imaging
The 3.0-T system (GE Discovery MR750; GE Healthcare, Milwaukee, WI, USA) with an eight-channel dedicated breast coil was used. Both breasts were imaged simultaneously. Premenopausal females were examined at day 7 to day 14 of the menstrual cycle. (4) Axial T1-weighted three-dimensional dynamic gradient echo fat sequence (VIBRANT) (TR/TE, 3.9/1.7; flip angle, 5°; field of view, 360 mm × 360 mm; matrix size, 348 × 348; and slice thickness, 1.8 mm). Dynamic contrast-enhanced image acquisition started immediately after the Gadodiamide (0.2 mmol/kg body weight, rate of 2 ml/s) and the saline injection in turn. There were 7 sequences without time gaps, and each sequence lasted for 60 s.
Image analysis
MRI analysis was carried out by two experienced radiologists independently in a blinded way. Each final decision was made based on the agreement of these two radiologists.
GE workstation software (Advantage Windows Workstation 4.6; GE Healthcare) was used for ADC measurement. Single region of interest (ROI) was placed on the ADC images. ADC values were automatically calculated on the ADC maps, with the location identical to that of the DWI image and dynamic contrast-enhanced image. We placed a single ROI smaller than lesion in the solid part of lesion and avoided the necrotic and hemorrhagic regions as indicated by T2-weighted image and T1-weighted image. The ROI size was consistent among multiple measurements. The minimum ADC (ADC-min) value was defined as the lowest one of three values [ Figures 1c-3c] . The mean ADC value was defined as the average of three measurements.
Statistical analysis
Data were expressed as mean ± standard deviation. The statistical analysis was performed using SPSS software (IBM SPSS Statistics 25.0, Chicago, IL, USA). The one-way ANOVA and LSD test were used to compare the difference in ADC-min value. The diagnostic value of ADC-min value in differentiating DCIS and invasive cancer was analyzed using student-t test for independent samples and receiver operating characteristic (ROC) analysis. P < 0.05 was considered as statistically significant. According to the pathological type, the minimum, maximum, and mean ADC-min values of breast cancer were presented in Table 1 . Table 1 showed that the mean ADC-min values of IDC, IDC-DCIS, and DCIS were significantly different (P < 0.01), in ascending order of IDC, IDC-DCIS, and DCIS. In particular, significant difference was found in mean ADC-min value between IDC and DCIS (P < 0.01).
RESULTS
Pathological type and apparent diffusion coefficient-min values
Apparent diffusion coefficient-min value in ductal carcinoma in situ diagnosis
To assess the role of ADC-min in diagnosis of the DCIS, the cases were divided into the DCIS and invasive cancer (IDC and IDC-DCIS) groups. It was showed that the mean ADC-min value in the DCIS was (1.24 ± 0.17) ×10 −3 mm 2 /s, while the mean ADC-min value in the invasive cancer group was (1.0 ± 0.16) ×10 −3 mm 2 /s (P < 0.01) [ Figure 4 ]. ROC analysis showed that both the ADC-min value and mean ADC value had great significance in the differential diagnosis of DCIS, with the area under the curve (AUC) of 0.85 and 0.84, respectively (both P < 0.01). The ADC-min threshold value was 1.02 × 10 −3 mm 2 /s, with sensitivity of 92.9% and specificity of 57.7%. The threshold for mean ADC value was 1.11 × 10 −3 mm 2 /s, with sensitivity of 78.6% and specificity of 71.4% [ Figure 5 and Table 2 ]. These results suggest that the ADC-min values have diagnostic value for DCIS.
DISCUSSION
Breast cancer is a heterogeneous tumor. [4, 16] The lowest cellular zone has the maximum ADC value, while the highest cellular zone has the minimum ADC value. [16] In addition, the components of fibrosis and necrosis in tumors may also affect the ADC values. [16] Thus, the mean ADC value cannot reflect the malignancy of tumors. In this study, we used the ADC-min value, which may represent the most malignant parts of tumors. [16] The application of the ADC-min values in breast cancer has been reported. [16] [17] [18] [19] [20] Most of these mentioned studies used multiple ROI method in breast MRI, and the lowest mean ADC value with multiple small ROIs in the lesion was defined as the ADC-min value. However, the multiple ROI method is time-consuming and thus has limited clinical application. [16] [17] [18] 20] In the present study, we placed a single ROI smaller than lesion in the solid tumor and avoided the necrotic and fibrotic regions. The ROI size was consistent among multiple measurements, and ADC-min value was obtained from each lesion. This method has feasibility in clinical settings and has been previously reported. [19] In this study −3 mm 2 /s. The ADC-min values among IDC, IDC-DCIS, and DCIS showed significant differences. The lower ADC values of IDC may be caused by the higher cellular density and smaller extracellular space. [21] There was overlapping of the ADC-min for the three types of breast cancer, which is probably caused by tumor heterogeneity. [4] So far, only one study reported the differentiation among IDC, IDC-DCIS, and DCIS. [22] It showed that volume-based ADC values could distinguish between IDC, IDC-DCIS, and DCIS; however, this method needs additional time and effort. Our study showed consistent results [22] but with simpler and more feasible method.
Early detection and management of DCIS is of high importance because DCIS can develop into invasive breast cancer, which is lethal. [23] In recent years, there have been only two reports on the clinical value of DWI in the differentiation between DCIS and invasive cancer in breast cancer patients. [24, 25] These studies showed that ADC could be used as an imaging marker for breast cancer diagnosis. In this study, the ADC-min value of DCIS and invasive cancer were (1.24 ± 0.17) ×10 −3 and (1.0 ± 0.16) ×10 −3 mm 2 /s, respectively. The mean ADC-min value of DCIS was higher than invasive cancer probably because cancer cells of DCIS mainly spread in the duct, and the cell density is lower than invasive cancer, while the invasive cancer is a densely packed tumor and has smaller extracellular space. [21] There were significant differences in mean ADC-min value between the DCIS and invasive groups, consistent with previous studies. [24, 25] The cutoff ADC-min (1.02 × 10 −3 mm 2 /s) was used to differentiate DCIS and invasive cancer, with sensitivity of 92.9.0% and specificity of 57.7%. Our results from the ROC analysis showed that ADC-min value had great significance in the diagnosis of DCIS, with the AUC of 0.85. Interestingly, the cutoff value, diagnostic sensitivity, and diagnostic specificity of ADC-min were similar to those of mean ADC value. This may be caused by the small sample size of this study. However, the measurement method for ADC-min is simpler and more practical. Further study is warranted. Receiver operating characteristic curve analysis. The receiver operating characteristic curve for minimum apparent diffusion coefficient and mean apparent diffusion coefficient value in ductal carcinoma in situ diagnosis was shown
